Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON34025Not yet recruiting
Randomised, double-blind trial in ametropia comparing Cyclopentolate + cyclopentolate with Cyclopentolate + tropicamide (2 arms). Primary endpoints: Residual accommodation (depth of cycloplegia), Recuperation time of ciliary paralysis and 1 more. Planned start Sep 2010; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON34025.